Evaluation of diabetic retinopathy severity on ultrawide field colour images compared with ultrawide fluorescein angiograms

PurposeTo compare Early Treatment Diabetic Retinopathy Study (ETDRS) diabetic retinopathy (DR) severity on ultrawide field (UWF) colour imaging (CI) and UWF fluorescein angiography (FA).DesignCross-sectional retrospective review.SubjectsPatients with diabetes mellitus and at least mild non-prolifera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of ophthalmology 2023-04, Vol.107 (4), p.534-539
Hauptverfasser: Ashraf, Mohamed, AbdelAl, Omar, Shokrollahi, Siamak, Pitoc, Cloyd M, Aiello, Lloyd Paul, Silva, Paolo S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 539
container_issue 4
container_start_page 534
container_title British journal of ophthalmology
container_volume 107
creator Ashraf, Mohamed
AbdelAl, Omar
Shokrollahi, Siamak
Pitoc, Cloyd M
Aiello, Lloyd Paul
Silva, Paolo S
description PurposeTo compare Early Treatment Diabetic Retinopathy Study (ETDRS) diabetic retinopathy (DR) severity on ultrawide field (UWF) colour imaging (CI) and UWF fluorescein angiography (FA).DesignCross-sectional retrospective review.SubjectsPatients with diabetes mellitus and at least mild non-proliferative DR on UWF-CI.MethodsUWF-CI and UWF-FA images acquired within 1 month of each other were evaluated independently using ETDRS DR Severity Scale (DRSS) for colour photography adapted for UWF-CI and UWF-FA. Extent of non-perfusion (NP, mm2) was determined from UWF-FA images.Main outcome measuresAgreement rate between DRSS on UWF-CI and UWF-FA.ResultsImages from 218 eyes of 137 patients with diabetes were evaluated. Agreement rate for DRSS between UWF-CI and UWF-FA was moderate to substantial (K=0.46, Kw=0.65). Over-all, DRSS was worse in 73 (33.5%) eyes on UWF-FA and in 16 (7.3%) on UWF-CI. Compared to UWF-CI, UWF-FA identified more severe DRSS in 26.5% (1 step) and 7.34% (≥2 steps) of eyes. DRSS was worse than UWF-FA in 56 (51.4%) in early DR (ETDRS levels 20–47, N=109) and 17 (15.6%) in eyes with severe DR (53 and higher, N=109). In this cohort, the extent of NP significantly increased as eyes approach moderate non-proliferative DR (levels 43–47, p=0.0065).ConclusionWhen evaluating UWF-FA images using the ETDRS colour severity scale, DRSS is graded as more severe in a substantial number of eyes than when evaluating UWF-CI. It is uncertain how the DRSS levels using UWF-FA translate to clinical outcomes, but the additional lesions detected might provide added prognostic value. These and other recent data emphasise the need of obtaining outcome data based on UWF-FA and the potential need to develop DRSS specifically tailored for UWF-FA images.
doi_str_mv 10.1136/bjo-2022-322163
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2768244162</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2768244162</sourcerecordid><originalsourceid>FETCH-LOGICAL-b389t-9cbdd453d2e221b8ee1f166bb2c1b7137a6c95c8992d964c24c2a4e3f4f3881b3</originalsourceid><addsrcrecordid>eNp9kctrFTEUxoMo9ra6dicBN4KMnZNk8lhKqQ8ouNH1kMeZ21xmJtdkpuXSf74ptz4QFELCCb_zncdHyCto3wNwee52qWEtYw1nDCR_QjYgpK5fyjwlm7ZtVQMg4YSclrKrIZOgnpMTLqU0SokNubu8seNql5hmmgYaonW4RE9zvee0t8v1gRa8wRyXA63MOi7Z3saAdIg4BurTmNZM42S3WGo07W3GQG_jcv0nO64pY_EYZ2rnbUzbbKfygjwb7Fjw5eN7Rr5_vPx28bm5-vrpy8WHq8ZxbZbGeBeC6HhgWId0GhEGkNI55sEp4MpKbzqvjWHBSOFZPVYgH8TAtQbHz8jbo-4-px8rlqWfYu1lHO2MaS09U1IzIUCyir75C93V8ebaXaW06Zjgmv-fkopz6FhXqfMj5XMqJePQ73PdUz700PYP7vXVvf7Bvf7oXs14_ai7ugnDL_6nXRV4dwTctPtd819y94-apH8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2767331525</pqid></control><display><type>article</type><title>Evaluation of diabetic retinopathy severity on ultrawide field colour images compared with ultrawide fluorescein angiograms</title><source>MEDLINE</source><source>PubMed Central</source><creator>Ashraf, Mohamed ; AbdelAl, Omar ; Shokrollahi, Siamak ; Pitoc, Cloyd M ; Aiello, Lloyd Paul ; Silva, Paolo S</creator><creatorcontrib>Ashraf, Mohamed ; AbdelAl, Omar ; Shokrollahi, Siamak ; Pitoc, Cloyd M ; Aiello, Lloyd Paul ; Silva, Paolo S</creatorcontrib><description>PurposeTo compare Early Treatment Diabetic Retinopathy Study (ETDRS) diabetic retinopathy (DR) severity on ultrawide field (UWF) colour imaging (CI) and UWF fluorescein angiography (FA).DesignCross-sectional retrospective review.SubjectsPatients with diabetes mellitus and at least mild non-proliferative DR on UWF-CI.MethodsUWF-CI and UWF-FA images acquired within 1 month of each other were evaluated independently using ETDRS DR Severity Scale (DRSS) for colour photography adapted for UWF-CI and UWF-FA. Extent of non-perfusion (NP, mm2) was determined from UWF-FA images.Main outcome measuresAgreement rate between DRSS on UWF-CI and UWF-FA.ResultsImages from 218 eyes of 137 patients with diabetes were evaluated. Agreement rate for DRSS between UWF-CI and UWF-FA was moderate to substantial (K=0.46, Kw=0.65). Over-all, DRSS was worse in 73 (33.5%) eyes on UWF-FA and in 16 (7.3%) on UWF-CI. Compared to UWF-CI, UWF-FA identified more severe DRSS in 26.5% (1 step) and 7.34% (≥2 steps) of eyes. DRSS was worse than UWF-FA in 56 (51.4%) in early DR (ETDRS levels 20–47, N=109) and 17 (15.6%) in eyes with severe DR (53 and higher, N=109). In this cohort, the extent of NP significantly increased as eyes approach moderate non-proliferative DR (levels 43–47, p=0.0065).ConclusionWhen evaluating UWF-FA images using the ETDRS colour severity scale, DRSS is graded as more severe in a substantial number of eyes than when evaluating UWF-CI. It is uncertain how the DRSS levels using UWF-FA translate to clinical outcomes, but the additional lesions detected might provide added prognostic value. These and other recent data emphasise the need of obtaining outcome data based on UWF-FA and the potential need to develop DRSS specifically tailored for UWF-FA images.</description><identifier>ISSN: 0007-1161</identifier><identifier>EISSN: 1468-2079</identifier><identifier>DOI: 10.1136/bjo-2022-322163</identifier><identifier>PMID: 36669774</identifier><language>eng</language><publisher>BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd</publisher><subject>Agreements ; Clinical science ; Clinical trials ; Color ; Cross-Sectional Studies ; Diabetes ; Diabetes Mellitus ; Diabetic retinopathy ; Diabetic Retinopathy - diagnosis ; Disease ; Fluorescein Angiography ; Fluoresceins ; Humans ; Medical imaging ; Photography ; Photography - methods ; Retina</subject><ispartof>British journal of ophthalmology, 2023-04, Vol.107 (4), p.534-539</ispartof><rights>Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b389t-9cbdd453d2e221b8ee1f166bb2c1b7137a6c95c8992d964c24c2a4e3f4f3881b3</citedby><cites>FETCH-LOGICAL-b389t-9cbdd453d2e221b8ee1f166bb2c1b7137a6c95c8992d964c24c2a4e3f4f3881b3</cites><orcidid>0000-0003-4231-2566 ; 0000-0001-8024-9348</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36669774$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ashraf, Mohamed</creatorcontrib><creatorcontrib>AbdelAl, Omar</creatorcontrib><creatorcontrib>Shokrollahi, Siamak</creatorcontrib><creatorcontrib>Pitoc, Cloyd M</creatorcontrib><creatorcontrib>Aiello, Lloyd Paul</creatorcontrib><creatorcontrib>Silva, Paolo S</creatorcontrib><title>Evaluation of diabetic retinopathy severity on ultrawide field colour images compared with ultrawide fluorescein angiograms</title><title>British journal of ophthalmology</title><addtitle>Br J Ophthalmol</addtitle><addtitle>Br J Ophthalmol</addtitle><description>PurposeTo compare Early Treatment Diabetic Retinopathy Study (ETDRS) diabetic retinopathy (DR) severity on ultrawide field (UWF) colour imaging (CI) and UWF fluorescein angiography (FA).DesignCross-sectional retrospective review.SubjectsPatients with diabetes mellitus and at least mild non-proliferative DR on UWF-CI.MethodsUWF-CI and UWF-FA images acquired within 1 month of each other were evaluated independently using ETDRS DR Severity Scale (DRSS) for colour photography adapted for UWF-CI and UWF-FA. Extent of non-perfusion (NP, mm2) was determined from UWF-FA images.Main outcome measuresAgreement rate between DRSS on UWF-CI and UWF-FA.ResultsImages from 218 eyes of 137 patients with diabetes were evaluated. Agreement rate for DRSS between UWF-CI and UWF-FA was moderate to substantial (K=0.46, Kw=0.65). Over-all, DRSS was worse in 73 (33.5%) eyes on UWF-FA and in 16 (7.3%) on UWF-CI. Compared to UWF-CI, UWF-FA identified more severe DRSS in 26.5% (1 step) and 7.34% (≥2 steps) of eyes. DRSS was worse than UWF-FA in 56 (51.4%) in early DR (ETDRS levels 20–47, N=109) and 17 (15.6%) in eyes with severe DR (53 and higher, N=109). In this cohort, the extent of NP significantly increased as eyes approach moderate non-proliferative DR (levels 43–47, p=0.0065).ConclusionWhen evaluating UWF-FA images using the ETDRS colour severity scale, DRSS is graded as more severe in a substantial number of eyes than when evaluating UWF-CI. It is uncertain how the DRSS levels using UWF-FA translate to clinical outcomes, but the additional lesions detected might provide added prognostic value. These and other recent data emphasise the need of obtaining outcome data based on UWF-FA and the potential need to develop DRSS specifically tailored for UWF-FA images.</description><subject>Agreements</subject><subject>Clinical science</subject><subject>Clinical trials</subject><subject>Color</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Diabetes Mellitus</subject><subject>Diabetic retinopathy</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>Disease</subject><subject>Fluorescein Angiography</subject><subject>Fluoresceins</subject><subject>Humans</subject><subject>Medical imaging</subject><subject>Photography</subject><subject>Photography - methods</subject><subject>Retina</subject><issn>0007-1161</issn><issn>1468-2079</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kctrFTEUxoMo9ra6dicBN4KMnZNk8lhKqQ8ouNH1kMeZ21xmJtdkpuXSf74ptz4QFELCCb_zncdHyCto3wNwee52qWEtYw1nDCR_QjYgpK5fyjwlm7ZtVQMg4YSclrKrIZOgnpMTLqU0SokNubu8seNql5hmmgYaonW4RE9zvee0t8v1gRa8wRyXA63MOi7Z3saAdIg4BurTmNZM42S3WGo07W3GQG_jcv0nO64pY_EYZ2rnbUzbbKfygjwb7Fjw5eN7Rr5_vPx28bm5-vrpy8WHq8ZxbZbGeBeC6HhgWId0GhEGkNI55sEp4MpKbzqvjWHBSOFZPVYgH8TAtQbHz8jbo-4-px8rlqWfYu1lHO2MaS09U1IzIUCyir75C93V8ebaXaW06Zjgmv-fkopz6FhXqfMj5XMqJePQ73PdUz700PYP7vXVvf7Bvf7oXs14_ai7ugnDL_6nXRV4dwTctPtd819y94-apH8</recordid><startdate>20230401</startdate><enddate>20230401</enddate><creator>Ashraf, Mohamed</creator><creator>AbdelAl, Omar</creator><creator>Shokrollahi, Siamak</creator><creator>Pitoc, Cloyd M</creator><creator>Aiello, Lloyd Paul</creator><creator>Silva, Paolo S</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4231-2566</orcidid><orcidid>https://orcid.org/0000-0001-8024-9348</orcidid></search><sort><creationdate>20230401</creationdate><title>Evaluation of diabetic retinopathy severity on ultrawide field colour images compared with ultrawide fluorescein angiograms</title><author>Ashraf, Mohamed ; AbdelAl, Omar ; Shokrollahi, Siamak ; Pitoc, Cloyd M ; Aiello, Lloyd Paul ; Silva, Paolo S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b389t-9cbdd453d2e221b8ee1f166bb2c1b7137a6c95c8992d964c24c2a4e3f4f3881b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Agreements</topic><topic>Clinical science</topic><topic>Clinical trials</topic><topic>Color</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Diabetes Mellitus</topic><topic>Diabetic retinopathy</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>Disease</topic><topic>Fluorescein Angiography</topic><topic>Fluoresceins</topic><topic>Humans</topic><topic>Medical imaging</topic><topic>Photography</topic><topic>Photography - methods</topic><topic>Retina</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ashraf, Mohamed</creatorcontrib><creatorcontrib>AbdelAl, Omar</creatorcontrib><creatorcontrib>Shokrollahi, Siamak</creatorcontrib><creatorcontrib>Pitoc, Cloyd M</creatorcontrib><creatorcontrib>Aiello, Lloyd Paul</creatorcontrib><creatorcontrib>Silva, Paolo S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ashraf, Mohamed</au><au>AbdelAl, Omar</au><au>Shokrollahi, Siamak</au><au>Pitoc, Cloyd M</au><au>Aiello, Lloyd Paul</au><au>Silva, Paolo S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of diabetic retinopathy severity on ultrawide field colour images compared with ultrawide fluorescein angiograms</atitle><jtitle>British journal of ophthalmology</jtitle><stitle>Br J Ophthalmol</stitle><addtitle>Br J Ophthalmol</addtitle><date>2023-04-01</date><risdate>2023</risdate><volume>107</volume><issue>4</issue><spage>534</spage><epage>539</epage><pages>534-539</pages><issn>0007-1161</issn><eissn>1468-2079</eissn><abstract>PurposeTo compare Early Treatment Diabetic Retinopathy Study (ETDRS) diabetic retinopathy (DR) severity on ultrawide field (UWF) colour imaging (CI) and UWF fluorescein angiography (FA).DesignCross-sectional retrospective review.SubjectsPatients with diabetes mellitus and at least mild non-proliferative DR on UWF-CI.MethodsUWF-CI and UWF-FA images acquired within 1 month of each other were evaluated independently using ETDRS DR Severity Scale (DRSS) for colour photography adapted for UWF-CI and UWF-FA. Extent of non-perfusion (NP, mm2) was determined from UWF-FA images.Main outcome measuresAgreement rate between DRSS on UWF-CI and UWF-FA.ResultsImages from 218 eyes of 137 patients with diabetes were evaluated. Agreement rate for DRSS between UWF-CI and UWF-FA was moderate to substantial (K=0.46, Kw=0.65). Over-all, DRSS was worse in 73 (33.5%) eyes on UWF-FA and in 16 (7.3%) on UWF-CI. Compared to UWF-CI, UWF-FA identified more severe DRSS in 26.5% (1 step) and 7.34% (≥2 steps) of eyes. DRSS was worse than UWF-FA in 56 (51.4%) in early DR (ETDRS levels 20–47, N=109) and 17 (15.6%) in eyes with severe DR (53 and higher, N=109). In this cohort, the extent of NP significantly increased as eyes approach moderate non-proliferative DR (levels 43–47, p=0.0065).ConclusionWhen evaluating UWF-FA images using the ETDRS colour severity scale, DRSS is graded as more severe in a substantial number of eyes than when evaluating UWF-CI. It is uncertain how the DRSS levels using UWF-FA translate to clinical outcomes, but the additional lesions detected might provide added prognostic value. These and other recent data emphasise the need of obtaining outcome data based on UWF-FA and the potential need to develop DRSS specifically tailored for UWF-FA images.</abstract><cop>BMA House, Tavistock Square, London, WC1H 9JR</cop><pub>BMJ Publishing Group Ltd</pub><pmid>36669774</pmid><doi>10.1136/bjo-2022-322163</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4231-2566</orcidid><orcidid>https://orcid.org/0000-0001-8024-9348</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0007-1161
ispartof British journal of ophthalmology, 2023-04, Vol.107 (4), p.534-539
issn 0007-1161
1468-2079
language eng
recordid cdi_proquest_miscellaneous_2768244162
source MEDLINE; PubMed Central
subjects Agreements
Clinical science
Clinical trials
Color
Cross-Sectional Studies
Diabetes
Diabetes Mellitus
Diabetic retinopathy
Diabetic Retinopathy - diagnosis
Disease
Fluorescein Angiography
Fluoresceins
Humans
Medical imaging
Photography
Photography - methods
Retina
title Evaluation of diabetic retinopathy severity on ultrawide field colour images compared with ultrawide fluorescein angiograms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A00%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20diabetic%20retinopathy%20severity%20on%20ultrawide%20field%20colour%20images%20compared%20with%20ultrawide%20fluorescein%20angiograms&rft.jtitle=British%20journal%20of%20ophthalmology&rft.au=Ashraf,%20Mohamed&rft.date=2023-04-01&rft.volume=107&rft.issue=4&rft.spage=534&rft.epage=539&rft.pages=534-539&rft.issn=0007-1161&rft.eissn=1468-2079&rft_id=info:doi/10.1136/bjo-2022-322163&rft_dat=%3Cproquest_cross%3E2768244162%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2767331525&rft_id=info:pmid/36669774&rfr_iscdi=true